Impact of Highly Effective Modulator Therapy on the Cystic Fibrosis Microbiome
Impact of Highly Effective Modulator Therapy on the Cystic Fibrosis Microbiome
Recruiting · NCT05982795 · Registry updated 2025-12-16Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Impact of Highly Effective Modulator Therapy on the Cystic Fibrosis Microbiome | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Infant, Newborn, Diseases, cystic fibrosis, hereditary disease, lung disorder, pancreas disorder, respiratory system disorder | Recruiting | Not stated | 2025-12-16 | NCT05982795 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Dartmouth-Hitchcock Medical Center | 104 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Dartmouth-Hitchcock Medical Center | Lebanon | United States | 86 |